Granules India Ltd. benchmarking: Perfomance to industry peers

Financial

	Granules India	Solara Active Pharma	IOL Chem & Pharma
Operational Metrics
Pharmaceuticals
Manufacturing Capacity - Paracetamol	34560.0 MTPA	n/a	10800.0 MTPA
Number of ANDA's Approved By USFDA	68.0 .	n/a	n/a
Manufacturing Capacity - Metformin	2000.0 MTPA	n/a	7200.0 MTPA
Number of ANDA's Filed in USA	88.0 .	n/a	n/a
Manufacturing Capacity - Ibuprofen	4800.0 MTPA	5000.0 MTPA	12000.0 MTPA
US DMF Filings	41.0 .	230.0 .	n/a
Europe DMF Filings	11.0 .	n/a	n/a
Total reactor capacity	626.5 kL	n/a	n/a
Number of ANDA's Filed	130.0 .	n/a	n/a
Number of ANDA's Approved	92.0 .	n/a	n/a
R&D as a % of Total Sales	5.4 %	n/a	1.01 %
Financials
5 yr Average ROE	17.11 %	-10.41 %	8.9 %
5yr average Equity Multiplier	1.71	1.99	1.42
5yr Average Asset Turnover Ratio	0.83	0.54	0.99
5yr Avg Net Profit Margin	11.91 %	-7.28 %	6.28 %
Price to Book	3.46	2.14	1.46
P/E	26.86	419.25	22.02
5yr Avg Cash Conversion Cycle	-44.08 Days	28.67 Days	37.81 Days
Inventory Days	72.16 Days	111.94 Days	65.55 Days
Days Receivable	47.23 Days	95.97 Days	86.45 Days
Days Payable	127.76 Days	146.85 Days	100.1 Days
5yr Average Interest Coverage Ratio	15.94	0.25	15.8
5yr Avg ROCE	21.96 %	2.1 %	12.63 %
5yr Avg Operating Profit Margin	21.18 %	9.63 %	10.64 %
5 yr average Debt to Equity	0.38	0.7	0.04
5yr CAGR Net Profit	-1.81 %	-69.98 %	-9.63 %
5yr Average Return on Assets	10.0 %	-3.67 %	6.27 %
Shareholdings
Promoter Holding	38.82 %	42.01 %	52.62 %
Share Pledged by Promoters	0.0	35.32 %	0.0
Change in Promoter Holding (3 Yrs)	-3.11 %	1.61 %	8.93 %
Change in Mutual Fund Holding (3 Yrs)	3.06 %	-1.37 %	0.0

	Granules India	Solara Active Pharma	IOL Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Paracetamol 46.0 Metformin 22.0 Ibuprofen 10.0 GGF 4.0 MCB 3.0 Ibuprofen 0 Active Pharmaceutical Ingredients (API) 0 API 0 Chemicals 0 Ethyl Acetate 0 Pantaprazole 0 Clopidogrel 0 Metformin 0 Others 15.0	Product Wise Break-Up Chemicals 0 Clopidogrel 0 GGF 0 API 0 MCB 0 Active Pharmaceutical Ingredient (API) 100.0 Metformin 0 Ibuprofen 0 Paracetamol 0 Pantaprazole 0 Ethyl Acetate 0	Product Wise Break-Up Chemicals 43.0 Clopidogrel 0 GGF 0 API 20.0 MCB 0 Active Pharmaceutical Ingredients (API) 0 Metformin 0 Ibuprofen 37.0 Paracetamol 0 Pantaprazole 0 Ethyl Acetate 0
Segment Break-Up	Segment Break-Up Formulations 74.0 Active Pharmaceutical Ingredient (API) 14.0 PFI 10.0 0 Pharmaceuticals 0 Others 2.0	-	Segment Break-Up Pharmaceutical 53.31 Chemicals 45.5 Active Pharmaceutical Ingredient (API) 0 Formulations 0 PFI 0 Others 1.19
Location Wise Break-Up	Location Wise Break-Up USA 77.0 Europe 14.0 Rest of the World 9.0 Canada 0 AMEA 0 Latin America 0 India 0 South America 0 North America 0 Asia Pacific 0	Location Wise Break-Up North America 5.85 AMEA 0 Rest of the World 0 South America 4.66 Asia Pacific 65.31 USA 0 India 0 Europe 20.24 Canada 0 Latin America 0 Others 3.94	Location Wise Break-Up North America 0 AMEA 0 Rest of the World 24.4 South America 0 Asia Pacific 0 USA 0 India 75.6 Europe 0 Canada 0 Latin America 0